SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of earliest event reported: January 28, 2003
HYSEQ, INC.
| Nevada | 000-22873 | 36-3855489 | ||
|
|
||||
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
670 Almanor Avenue, Sunnyvale, California 94085
(408) 524-8100
N/A
| ITEM 5. OTHER EVENTS. | ||||||||
| ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS | ||||||||
| SIGNATURES | ||||||||
| EXHIBIT INDEX | ||||||||
| EXHIBIT 99.1 | ||||||||
| ITEM 5. | OTHER EVENTS. |
Hyseq, Inc. and Variagenics, Inc. today issued a press release announcing that they have received approval from their respective shareholders for the merger of the two companies. The press release is attached hereto as Exhibit 99.1 and incorporated by reference herein in its entirety.
In response to a question during the Hyseq stockholders meeting regarding Hyseq’s stock price, Hyseq management stated that while Hyseq had not received any notification from Nasdaq regarding noncompliance with Nasdaq’s requirement of a minimum stock price of $1.00 per share, management would consider a number of alternatives in the future to ensure compliance with this requirement, including without limitation a potential reverse stock split.
| ITEM 7. | FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS |
| (c) | Exhibits |
| 99.1 | Press Release, dated January 28, 2003 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| HYSEQ, INC. (Registrant) |
||||||
| By: | /s/ Peter S. Garcia | |||||
| Peter S. Garcia Senior Vice President and Chief Financial Officer |
||||||
| Dated: January 28, 2003 | ||||||
EXHIBIT INDEX
| Exhibit No |
Description | |
|
|
||
| 99.1 | Press Release, dated January 28, 2003 |